Tilray and other cannabis stocks soar as Trump is reportedly ready to reclassify the substance

Market Intelligence Analysis

AI-Powered
Why This Matters

FinBERT analysis of financial text showing neutral sentiment with 94.1% confidence.

Sentiment
Neutral
AI Confidence
94%
Time Horizon
Short Term

Article Context

Note: This is a brief excerpt for context. Click below to read the full article on the original source.

The move, which could open up medical research on cannabis as well as banking services for growers, follows an executive order to reclassify the substance in December.

Continue Reading
Full article on MarketWatch
Read Full Article
Original article published by MarketWatch on April 22, 2026.
Analysis and insights provided by AnalystMarkets AI.